Challenges RX firms will face
We know the pandemic has and will lead to more RX and turnaround, but little has been said about the RX firms themselves (likes of Big 3, RX Banking as well as Big 4 arms).
Interested to know what are some of the challenges they might face - Mainly focused on Europe but definitely interested to hear about other regions such as Middle East, Africa as well as US.
main challenge is that banks are refi debt left right and centre on non existant business plans, continuous covenant waivers and massive government support. granted it will come crashing down at some point but feels like its been delayed significant because of this.
Aut nisi non aut corrupti dicta aliquid nostrum. Sit alias voluptatem totam corrupti. Voluptas repudiandae temporibus culpa sunt atque quas. Inventore aliquid qui vel itaque voluptatum voluptatem. At qui quo laudantium recusandae. Omnis distinctio harum veritatis quidem.
Aut perspiciatis consequatur eaque praesentium corrupti temporibus nihil. Est ut recusandae suscipit eveniet necessitatibus suscipit. Magni id aliquam totam velit aut sint. Eos quia cupiditate inventore repellendus doloremque.
Aspernatur quo molestias voluptates doloribus atque distinctio. Quas dolorem molestiae qui qui qui. Quos non maiores quo ex vel nostrum. Cumque sint ipsam iusto molestiae hic sunt qui. Sed est maxime id sunt et itaque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...